Pre-existing cancer exacerbates cerebral ischemic stroke via Neurophilin-1 mediated recruitment of regulatory T cells into cancer tissue

被引:0
|
作者
Wang, L. [1 ,2 ]
Zhou, Y. [1 ]
Yu, W. [1 ]
Li, P. [1 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Anesthesiol, Shanghai, Peoples R China
[2] Second Mil Med Univ, Dept Anesthesiol, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BS11-4
引用
收藏
页码:48 / 49
页数:2
相关论文
共 41 条
  • [21] NOVEL MECHANISM OF ACQUIRED PLATINUM RESISTANCE FOR BRCA1-DRIVEN MALIGNANCIES: RAPID EXPANSION OF PRE-EXISTING BRCA1-PROFICIENT TUMOR CELLS DURING NEOADJUVANT THERAPY FOR OVARIAN CANCER
    Imyanitov, E.
    Berlev, I.
    Gorodnova, T.
    Savonevich, E.
    Ivantsov, A.
    Preobrazhenskaya, E.
    Togo, A.
    Sokolenko, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A138 - A138
  • [22] ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression
    Zhang, Huanling
    Li, Yanyan
    Liu, Xiaoping
    Liang, Zhaoduan
    Yan, Mengyong
    Liu, Qiang
    Chen, Anan
    Bao, Yifeng
    Zhou, Chengzhi
    Li, Shiyue
    Yee, Cassian
    Li, Yi
    IMMUNOLOGY, 2018, 155 (02) : 238 - 250
  • [23] Novel mechanism of platinum resistance: Rapid selection of pre-existing BRCA1-proficient tumor cells during neoadjuvant chemotherapy (NACT) for ovarian cancer (OC) in BRCA1 germ-line mutation carriers
    Imyanitov, E.
    Savonevich, E.
    Ivantsov, A.
    Gorodnova, T.
    Preobrazhenskaya, E.
    Kleshchov, M.
    Kuligina, E. S.
    Sokolenko, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [24] Loss of the MLL3 tumor suppressor accelerates breast tumor onset via HIF1a-induced CCL2-mediated recruitment of CCR2+ regulatory T cells
    Boutet, Marie
    Erler, Piril
    Nishitani, Kenta
    Couturier, Nicole
    Zhang, Zheng
    Barbieux, Emeline
    Guillen, Erik
    Suzuki, Masako
    Lauvau, Gregoire
    Guo, Wenjun
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [25] Targeting CDCP1 boost CD8+T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway
    Huang, Hua
    Pan, Yuwen
    Mai, Qiuwen
    Zhang, Chunyu
    Du, Qiqiao
    Liao, Yuandong
    Qin, Shuhang
    Chen, Yili
    Huang, Jiaming
    Li, Jie
    Liu, Tianyu
    Zou, Qiaojian
    Zhou, Yijia
    Yuan, Li
    Wang, Wei
    Liang, Yanchun
    Pan, Chao Yun
    Liu, Junxiu
    Yao, Shuzhong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
  • [26] PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+T regulatory cells
    Vidotto, Thiago
    Saggioro, Fabiano P.
    Jamaspishvili, Tamara
    Chesca, Deise L.
    Picanco de Albuquerque, Clarissa G.
    Reis, Rodolfo B.
    Graham, Charles H.
    Berman, David M.
    Siemens, D. Robert
    Squire, Jeremy A.
    Koti, Madhuri
    PROSTATE, 2019, 79 (09): : 969 - 979
  • [27] M2 MACROPHAGE-MEDIATED IMMUNE SUPPRESSION OF CHIMERIC ANTIGEN RECEPTOR T CELLS VIA PD-L1 SIGNALING IN PROSTATE CANCER
    Yamaguchi, Yukiko
    Gibson, Jackson
    Ou, Kevin
    Priceman, Saul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A238 - A238
  • [28] Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response?
    Razmkhah, Mahboobeh
    Jaberipour, Mansooreh
    Erfani, Nasrollah
    Habibagahi, Mojtaba
    Talei, Abdol-rasoul
    Ghaderi, Abbas
    CELLULAR IMMUNOLOGY, 2011, 266 (02) : 116 - 122
  • [29] Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice
    Sun, Ruixin
    Luo, Hong
    Su, Jingwen
    Di, Shengmeng
    Zhou, Min
    Shi, Bizhi
    Sun, Yansha
    Du, Guoxiu
    Zhang, Honghong
    Jiang, Hua
    Li, Zonghai
    MOLECULAR THERAPY, 2021, 29 (01) : 60 - 74
  • [30] Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
    Wang, Dan
    Yang, Li
    Yu, Weina
    Wu, Qian
    Lian, Jingyao
    Li, Feng
    Liu, Shasha
    Li, Aitian
    He, Zhiang
    Liu, Jinbo
    Sun, Zhenqiang
    Yuan, Weitang
    Zhang, Yi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)